Navigation Links
Gabon establishes national ethics committee
Date:3/26/2009

This release is available in French.

As the number of health research conducted in sub-Saharan Africa increases, so does the need for improved review of the ethical and scientific rigour of these trials. As we work on increasing the quality of research, we should also work on ensuring the safety of research participants. The recently established National Bioethics Committee of Gabon, which was established with the help of a grant from the European and Developing Countries Clinical Trials Partnership (EDCTP), is an example of the progress made to safeguard the well-being of African study participants.

The newly formed National Bioethics Committee for research of Gabon currently comprises 19 members that represent the three main Gabonese research institutes (USS Libreville, URM Lambarene and CIRMF Franceville), as well as relevant Gabonese hospitals and ministries. This initiative was started with the help of an EDCTP grant, training support from the Vienna School of Clinical Research, the Government of the Republic of Gabon and a committed team of Gabonese nationals. Consequently, with complementary support of other partners including WHO, UNESCO, AMANET and the Institut Pasteur of Dakar the Committee was officially established.

The committee is now operational and anticipates starting reviewing protocols for clinical trials soon. Negotiations are currently underway to include the committee in UNESCO's Global Ethics Observatory Database. Inclusion in this database means that not only the Committee has proven able to assess research, but that is also able to advise on ethical problems, formulate recommendations and foster debate, education and public awareness.

Why every country must have a National Ethics Committee

All clinical trials involving human participants must be reviewed and approved by a competent and independent research ethics committee. The research ethics committee must ensure that all studies are conducted in accordance with international ethics codes and guidelines. The ultimate goal of ethical review is that the dignity, rights, safety and wellbeing of research participants are protected.

In many African countries, ethics review capacity needs to be strengthened. Inadequate training, limited infrastructural facilities and lack of funding remain a big challenge. As the number of clinical trials conducted in Africa is growing, so is the requirement to empower the countries of Africa to conduct their own safety reviews of those trials. Currently, a number of organisations such as EDCTP, WHO, UNESCO, AMANET, COHRED and others are working hand-in-hand to help those countries to create and strengthen their institutional and National Bioethics Committees.

EDCTP strengthening of ethics committees in Africa

EDCTP is involved in the assessment of the ethics and regulatory environment of the countries where EDCTP-funded trials will be conducted and provides support in these areas. The ultimate aim is to reinforce the African ethics and regulatory environment in the long term. EDCTP has funded research ethics committees in Zimbabwe, Ghana, Malawi, Nigeria, Uganda and Gabon and is working hand-in-hand with COHRED to map ethics and regulatory capacity in Africa and with the World Health Organization (WHO) to strengthen the National Regulatory framework.


'/>"/>

Contact: Ilona van den Brink
media@edctp.org
31-703-494-422
Netherlands Organization for Scientific Research
Source:Eurekalert

Related medicine news :

1. Oxygen Biotherapeutics, Inc. Establishes Warfighter Division
2. APTAs Multidisciplinary Summit Establishes Opportunities for Physical Therapists to Drive Health Care Change
3. Renaissance Health Systems Establishes Strategic Alliance for Staffing Solutions to Healthcare Providers
4. Brooks Establishes Community Resource Center Web Site
5. Perceptive Informatics Establishes Alliance with AG Mednet to Bring Greater Efficiency and Quality to Medical Imaging-Based Trials
6. HPS Establishes Independent Website for its Patent-Pending Mood-Enhancing Compound Naturally Found in Sea Coral
7. Daiichi Sankyo, Inc. Establishes Subsidiary in Puerto Rico
8. Cystic Fibrosis Foundation Establishes Landmark Patient Assistance Foundation
9. Body-Jet Water-Assisted Liposuction Establishes New Standard for Liposuction and Fat Harvesting
10. Johnson & Johnson Establishes Wellness & Prevention Platform with Acquisition of HealthMedia, Inc.
11. Halleland Health Consulting Establishes URAC Accreditation Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... MedMatchPlus+ has ... chances of acceptance to a residency in a United States hospital. Being accepted ... the U.S. , According to data released by the ECFMG®, every year, 50 ...
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon ... the signature product of her research center at Bio-Logic Aqua Research® Water Life ... and the greatest number of sufferers of blindness. “We think that Nature’s Tears® ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the ... from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related ... though activity levels decline over time. The study, presented today at the ...
(Date:7/21/2017)... ONTARIO, CANADA (PRWEB) , ... July 21, 2017 ... ... give insight into why concussion rates are on the rise, say researchers presenting ... Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the patterns ...
(Date:7/20/2017)... ... 2017 , ... ChenMed , a leading provider of value-based care for ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family ... of Ambulatory Services for the UVA Health System, brings 30 years of highly relevant ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July ... UTHR ) announced today that it will report ... opens on Thursday, July 27, 2017. ... on Thursday, July 27, 2017, at 9:00 a.m. Eastern ... international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based ... today announced the completion of a $12.7 million Series A ... as well as the participation of existing investors. ... the support of New Ventures III and our current investors, ... the potential of our platform technology to transform the course ...
Breaking Medicine Technology: